Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-7579
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSiggelkow, Wulf-
dc.contributor.authorBoehm, Daniel-
dc.contributor.authorGebhard, Susanne-
dc.contributor.authorBattista, Marco-
dc.contributor.authorSicking, Isabel-
dc.contributor.authorLebrecht, Antje-
dc.contributor.authorSolbach, Christine-
dc.contributor.authorHellwig, Birte-
dc.contributor.authorRahnenfuhrer, Jorg-
dc.contributor.authorKoelbl, Heinz-
dc.contributor.authorGehrmann, Mathias-
dc.contributor.authorMarchan, Rosemarie-
dc.contributor.authorCadenas, Cristina-
dc.contributor.authorHengstler, Jan G.-
dc.contributor.authorSchmidt, Marcus-
dc.date.accessioned2022-08-19T10:06:33Z-
dc.date.available2022-08-19T10:06:33Z-
dc.date.issued2012-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/7593-
dc.description.abstractBACKGROUND: Inhibitors targeting the cell cycle-regulated aurora kinase A (AURKA) are currently being developed. Here, we examine the prognostic impact of AURKA in node-negative breast cancer patients without adjuvant systemic therapy (n = 766). METHODS: AURKA was analyzed using microarray-based gene-expression data from three independent cohorts of node-negative breast cancer patients. In multivariate Cox analyses, the prognostic impact of age, histological grade, tumor size, estrogen receptor (ER), and HER2 were considered. RESULTS: Patients with higher AURKA expression had a shorter metastasis-free survival (MFS) in theen_GB
dc.description.sponsorshipDFG, Open Access-Publizieren Universität Mainz / Universitätsmedizinde
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/2.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleExpression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patientsen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-7579-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleBMC cancerde
jgu.journal.volume12de
jgu.pages.alternativeArt. 562de
jgu.publisher.year2012-
jgu.publisher.nameSpringerde
jgu.publisher.placeLondonde
jgu.publisher.urihttp://dx.doi.org/10.1186/1471-2407-12-562de
jgu.publisher.issn1471-2407de
jgu.organisation.placeMainz-
jgu.identifier.pmid23186136-
jgu.subject.ddccode610de
opus.date.modified2015-09-17T09:36:57Z-
opus.subject.dfgcode04-205-
opus.organisation.stringFB 04: Medizin: Klinik und Poliklinik für Geburtshilfe und Frauenkrankheitende_DE
opus.identifier.opusid23651-
opus.importsourcepubmed-
opus.institute.number0445-
opus.metadataonlyfalse-
opus.type.contenttypeKeinede_DE
opus.type.contenttypeNoneen_EN
opus.affiliatedBattista, Marco-
opus.affiliatedSicking, Isabel-
opus.affiliatedLebrecht, Antje-
opus.affiliatedSolbach, Christine-
opus.affiliatedSchmidt, Marcus-
jgu.publisher.doi10.1186/1471-2407-12-562de
jgu.organisation.rorhttps://ror.org/023b0x485-
Appears in collections:DFG-OA-Publizieren (2012 - 2017)

Files in This Item:
  File Description SizeFormat
Thumbnail
expression_of_aurora_kinase_a-20220817163552627.pdf1.39 MBAdobe PDFView/Open